miR-125b, a target of CDX2, regulates cell differentiation through repression of the core binding factor in

Kang-Yu Lin1, Xing-Ju Zhang1, Dan-Dan Feng1

  • 1Key Laboratory of Gene Engineering of the Ministry of Education, State Key Laboratory for Biocontrol, Sun Yat-sen University, Guangzhou 510275, China.

Insights

A new study reveals that the transcription factor CDX2 up-regulates microRNA-125b (miR-125b) in myeloid cells. This process inhibits core binding factor β (CBFβ) translation, promoting leukemogenesis and hindering myeloid cell differentiation.

Area of Science:

  • Molecular Biology
  • Oncology
  • Gene Regulation

Background:

  • MicroRNA-125b (miR-125b) is deregulated and acts as an oncogene in various cancers, including hematopoietic malignancies.
  • The precise mechanisms driving miR-125b dysregulation in these cancers are not fully understood.
  • Identifying these mechanisms is crucial for understanding leukemogenesis and developing targeted therapies.

Purpose of the Study:

  • To identify factors contributing to miR-125b up-regulation in human hematopoietic malignancies.
  • To investigate the downstream targets of miR-125b involved in lineage-specific differentiation.
  • To elucidate the role of CDX2, miR-125b, and CBFβ in myeloid cell differentiation and leukemogenesis.

Main Methods:

  • Investigated the binding of transcription factor CDX2 to the miR-125b gene promoter.
  • Analyzed the effect of CDX2 levels on miR-125b expression in malignant myeloid cells.
  • Examined the impact of miR-125b on core binding factor β (CBFβ) translation.
  • Studied the role of all-trans-retinoic acid (ATRA) in modulating the CDX2-miR-125b-CBFβ pathway.

Main Results:

  • CDX2 directly binds to and activates the transcription of miR-125b in malignant myeloid cells.
  • Elevated CDX2 levels lead to increased miR-125b expression, which suppresses CBFβ translation.
  • This pathway inhibits myeloid cell differentiation, particularly granulocytic lineage, and promotes leukemogenesis.
  • All-trans-retinoic acid treatment reduces CDX2 activity, decreasing miR-125b transcription and restoring CBFβ levels, thereby inducing differentiation.

Conclusions:

  • A novel pathway involving CDX2, miR-125b, and CBFβ contributes to hematopoietic malignancies.
  • Deregulation of miR-125b and its associated factors represents a key mechanism in leukemogenesis.
  • Understanding this pathway provides new insights into the pathogenesis of hematopoietic malignancies and potential therapeutic targets.

Related Concept Videos

Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Lineage Commitment01:21

Lineage Commitment

Commitment is the  process whereby stem cells:
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...